Free Trial

Asthika Goonewardene - Truist Financial Analyst Performance

This page shows the methodology used to calculate Asthika Goonewardene's recommendation performance. Listed below are links to the research notes issued, the price targets issued by the analyst, and the stock's actual price 12 months from the date the research note was issued. These rankings are based on research reports from . Rankings are updated daily.

MarketBeat Analyst Ranking:
Average 12-Month ROI of Buy and Strong Buy Recommendations: ???%

CompanyReport DateReport Date Price12-Month
Price Target
Rating12-Month
Actual Price
12-Month
ROI
Details
Exelixis, Inc. stock logo
EXEL
Exelixis
7/29/2025$37.22$49.00Buy???%???%
Exelixis, Inc. stock logo
EXEL
Exelixis
7/15/2025$44.47$56.00Buy???%???%
Genmab A/S Sponsored ADR stock logo
GMAB
Genmab A/S
7/8/2025$21.33$46.00Buy???%???%
Exelixis, Inc. stock logo
EXEL
Exelixis
6/23/2025$43.61$55.00Buy???%???%
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
6/3/2025$116.20$155.00Buy???%???%
Mersana Therapeutics, Inc. stock logo
MRSN
Mersana Therapeutics
5/16/2025$8.33$250.00Buy???%???%
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
5/14/2025$28.41$71.00Buy???%???%
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
5/14/2025$0.93$10.00Buy???%???%
Genmab A/S Sponsored ADR stock logo
GMAB
Genmab A/S
3/11/2025$20.25$45.00Buy???%???%
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
3/3/2025$4.09$15.00Buy???%???%
CARGO Therapeutics, Inc. stock logo
CRGX
CARGO Therapeutics
1/30/2025$13.19$7.00Hold???%???%
Exelixis, Inc. stock logo
EXEL
Exelixis
1/27/2025$32.99$43.00Buy???%???%
Exelixis, Inc. stock logo
EXEL
Exelixis
1/15/2025$36.78$42.00Buy???%???%
Celularity, Inc. stock logo
CELU
Celularity
4/6/2022$94.00$100.00Hold???%???%
Celularity, Inc. stock logo
CELU
Celularity
10/19/2021$74.70$120.00Buy???%???%
Exelixis, Inc. stock logo
EXEL
Exelixis
7/8/2020$23.92$40.00Buy???%???%
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
6/8/2020$43.20$50.00Hold???%???%


Return to Analyst Rankings